1. A new link has been found between KCNK3 gene mutations and pulmonary arterial hypertension.
2. The mutations identified affect the ability of the KCNK3 ion channel to conduct current.
3. A drug known to stimulate KCNK3 channels can restore conductivity of some of the mutant channels in vitro.